The Role of Immunotherapy in Breast Cancer and Mechanisms of Immune Escape: What Surgeons Need to Know

By afschroeder • July 25, 2026

Graham DM, Lofftus S, Azizi L, Berkowitz MJ, Teshome M. The Role of Immunotherapy in Breast Cancer and Mechanisms of Immune Escape: What Surgeons Need to Know. Am Surg. 2026 Jul 24:31348261468304. doi: 10.1177/00031348261468304. Epub ahead of print. PMID: 42498515.

Tags: Breast, Hematology/Oncology, immunotherapy, Publications, surgical oncology

Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study

Rugo HS, Jhaveri K, Pernas S, Pistilli B, Im SA, De Laurentiis M, Wang S, Martínez Jañez N, Borges G, Cescon DW, Hattori M, Lu[...]

Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial

Wainberg ZA, Lee KW, Kim JG, Devoe C, Strickler JH, Baum J, Jia C, Kagey MH, Sirard CA, Stein A, Scott AJ, Pelster M, Moehler[...]

Neuroendocrine Tumor of the Breast in a Young Woman With MEN2A Syndrome

Vaghashia D, Sullivan P, Livhits MJ, Donangelo I, Laklouk I, Teshome M, Lipsyc-Sharf M. Neuroendocrine Tumor of the Breast in a Young Woman With MEN2A[...]